Wound 5 mg/ 20 mg/g ointment

Pharmacotherapeutic group: combined agent for wound healing.

1 g of ointment contains 20 mg of lidocaine hydrochloride and 5 mg of methyluracil.

Therapeutic indications
Agent for promotion of wound, trofic ulcer, furuncle, carbuncle, burn and other skin injury healing and prevention of infection.

The active substance of the ointment, methyluracil, promotes cell and epithelium regeneration, it also has anti-inflammatory and immunostimulating effect. The active substance lidocaine hydrochloride is a local anesthetic that reduces pain in the wound. Ointment also has bactericidal properties, which is provided by the excipient chinifuryl.

Doses and mode of administration
Following wound cleaning the ointment should be applied using sterile swabs impregnated with ointment, which should be changed every day. Duration of ointment application is from 7 to 14 days.

Package type and content
35 g of ointment in the aluminum tube.

Consult a doctor or pharmacist regarding the administration of the medicinal product!
Carefully read the patient information leaflet or information on the package!